Ann: Acrux Presents At Bioshares Biotech Summit, page-7

  1. 41 Posts.
    so if they're making topical generic products that are not protected by any patents, can someone help me understand, what is Acrux's competitive advantage in this? What makes their product pipeline any more likely to be commercially successful than any other topical generic that may come from the large global generic players? What am i missing?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.7¢
Change
-0.001(5.56%)
Mkt cap ! $6.931M
Open High Low Value Volume
1.8¢ 1.9¢ 1.7¢ $8.809K 495.6K

Buyers (Bids)

No. Vol. Price($)
5 266679 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 252359 2
View Market Depth
Last trade - 14.49pm 24/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.